These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 29661603)
1. Insulin-induced skin complication in an anti-insulin antibody positive patient with type 2 diabetes. Hamasaki H; Hamasaki Y Diabetes Metab Syndr; 2018 Sep; 12(5):829-830. PubMed ID: 29661603 [No Abstract] [Full Text] [Related]
2. Insulin, insulin antibodies and insulin autoantibodies. Winter WE; Jacobsen LM; Pittman D MLO Med Lab Obs; 2017 Feb; 49(2):16-18. PubMed ID: 30005474 [No Abstract] [Full Text] [Related]
3. Immunological insulin resistance due to insulin antibodies developed after cessation of insulin therapy in a patient with type 2 diabetes. Hirano M; Arima H; Oiso Y Diabetes Care; 2008 Nov; 31(11):e84. PubMed ID: 18955711 [No Abstract] [Full Text] [Related]
4. Animal insulin therapy induces a biased insulin antibody response that persists for years after introduction of human insulin. Oak S; Phan TH; Gilliam LK; Hirsch IB; Hampe CS Acta Diabetol; 2010 Jun; 47(2):131-5. PubMed ID: 19547910 [TBL] [Abstract][Full Text] [Related]
5. Recurrent hypoglycemia, a rare case of insulin autoimmune syndrome in a young African American male. Jendi MR; Tiwari N; Karim I Diabetes Metab Syndr; 2019; 13(3):2320-2321. PubMed ID: 31235174 [TBL] [Abstract][Full Text] [Related]
6. Binding characteristics and crossreactivity of insulin autoantibodies and insulin antibodies directed to three different insulin molecules. Jaeger C; Winter S; Eckhard M; Hardt P; Brendel MD; Bretzel RG Acta Diabetol; 2008 Sep; 45(3):191-4. PubMed ID: 18493700 [TBL] [Abstract][Full Text] [Related]
7. Antibodies as predictors of type 1 diabetes. Wilkin TJ Compr Ther; 1991 Jul; 17(7):3-10. PubMed ID: 1742966 [No Abstract] [Full Text] [Related]
9. Development of insulin antibodies and changes in titers over a long-term period in patients with type 2 diabetes. Hattori N; Duhita MR; Mukai A; Matsueda M; Shimatsu A Clin Chim Acta; 2014 Jun; 433():135-8. PubMed ID: 24642342 [TBL] [Abstract][Full Text] [Related]
10. Injection-site skin lesions following pen-injection treatment in a 59-year-old woman with insulin-treated Type 2 diabetes mellitus. Winkler G; Sápi Z; Pál B; Molnár L Diabet Med; 1997 Dec; 14(12):1078-9. PubMed ID: 9455937 [No Abstract] [Full Text] [Related]
11. [Insulin autoantibodies and insulin-induced antibodies in children with insulin-dependent diabetes]. Bridel MP; Tubiana-Rufi N; Levy-Marchal C Diabete Metab; 1992; 18(6):459-62. PubMed ID: 1297603 [TBL] [Abstract][Full Text] [Related]
12. [Case report; a case of type 2 diabetes mellitus with frequent hypoglycemia due to insulin antibodies after switching insulin product]. Takebe R; Odake Y; Muramae N; Okada Y; Nakamura T Nihon Naika Gakkai Zasshi; 2013 Nov; 102(11):2976-9. PubMed ID: 24450135 [No Abstract] [Full Text] [Related]
13. The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report. Hirai H; Ogata E; Kikuchi N; Kohno T; Machii N; Hasegawa K; Watanabe T; Satoh H J Med Case Rep; 2016 Jul; 10():202. PubMed ID: 27456688 [TBL] [Abstract][Full Text] [Related]
14. Severe insulin resistance due to anti-insulin antibodies: response to plasma exchange and immunosuppressive therapy. Greenfield JR; Tuthill A; Soos MA; Semple RK; Halsall DJ; Chaudhry A; O'Rahilly S Diabet Med; 2009 Jan; 26(1):79-82. PubMed ID: 19125765 [TBL] [Abstract][Full Text] [Related]
15. [Actual problems of diabetes mellitus]. Balabolkin MI Sov Med; 1989; (11):3-7. PubMed ID: 2697087 [No Abstract] [Full Text] [Related]
16. Autoimmune hypoglycemia in a type 2 diabetic patient with anti-insulin and insulin receptor antibodies. Sahin M; Tutuncu N; Guvener ND Diabetes Care; 2004 May; 27(5):1246-7; author reply 1247. PubMed ID: 15111569 [No Abstract] [Full Text] [Related]
17. Presence of anti-insulin natural autoantibodies in healthy cats and its interference with immunoassay for serum insulin concentrations. Nishii N; Takasu M; Kojima M; Hachisu T; Wakabayashi K; Iwasawa A; Maeda S; Ohba Y; Kitagawa H Domest Anim Endocrinol; 2010 Apr; 38(3):138-45. PubMed ID: 19850439 [TBL] [Abstract][Full Text] [Related]
19. Diagnostic algorithm and management of immune-mediated complications associated with subcutaneous insulin therapy. Jaeger C; Eckhard M; Brendel MD; Bretzel RG Exp Clin Endocrinol Diabetes; 2004 Sep; 112(8):416-21. PubMed ID: 15372360 [TBL] [Abstract][Full Text] [Related]
20. The insulin analog aspart: a safe alternative in insulin allergy. Airaghi L; Lorini M; Tedeschi A Diabetes Care; 2001 Nov; 24(11):2000. PubMed ID: 11679473 [No Abstract] [Full Text] [Related] [Next] [New Search]